A carregar cotações...

Previsão

Comprar
  4
Manter
  1
Vender
  1

Discussões na comunidade

  • 2 19
  • 2 Jahre altes Portfolio (Angestellt, 22 Jahre alt)

    Luca S. Luca S. I em Portfolio Roasts

    7 2
  • Stefan kauft Aktien

    S Stefan V em Portfolio Roasts

    13 32
  • Meinung / Verbesserungsvorschläge

    J Justin IV em Portfolio Roasts

    0 7
  • Portfolio

    M0 Marie.mar 03 V em Portfolio Roasts

    6 23

  • Antitrust case against Brau Union (Heineken) referred to the European Court of Justice

    The antitrust proceedings by the Austrian Federal Competition Authority (BWB) against Brau Union, part of the Heineken group, over alleged abuse of market power have been referred to the European Court of Justice. The BWB accuses the group of pressuring beverage retailers to prioritise selling its products. Heineken denies the allegations and complains of insufficient access to the case files; if convicted the company could face a fine of up to ten percent of group turnover. An ECJ decision can take more than a year, and the ongoing proceedings before the Cartel Court in Vienna remain unaffected. » Mais em kurier.at


  • Heineken beats expectations thanks to premium and non-alcoholic beer

    Heineken reports an organic volume increase of 4.8% in the third quarter and a sales rise of 4.6%, well above analysts' expectations of 2.9% and 3.5% respectively. The premium segment grew particularly strongly, by 11.5%; all regions contributed to the growth. New group CEO Rafa Oliveira is calling for a stronger performance culture and faster execution and plans to present details of his strategy in February. For the full year 2026, Heineken confirms its forecast of organic operating profit growth of 2% to 6%. » Mais em n-tv.de


  • Heineken warns of sales risk in British pubs from weight-loss injections

    Heineken warns that GLP-1 weight-loss drugs such as Ozempic or Wegovy could reduce alcohol cravings through increased feelings of fullness, endangering beer and cider sales in British pubs. The company recommended measures for publicans such as smaller beer glasses, alcohol-free alternatives and food pairings to cushion revenue losses. U.S. market data show households with GLP-1 users have about 7% lower alcohol spending after two years and roughly 13.5% less spending on beer; other spirits companies so far assess the risk as manageable. » Mais em manager-magazin.de


  • Heineken warns GLP-1 weight-loss drugs could dent UK beer and cider sales

    Heineken told UK pub and bar customers that the rise of GLP-1 drugs such as Wegovy and Ozempic can reduce desire to drink alcohol, leading to smaller serves and fewer pints per visit. The brewer advised promoting half-pints, low- and no-alcohol options and food pairings to mitigate potential declines in visits and spending. Heineken said it will monitor changing consumption patterns through 2027, while industry data on the impact remains mixed. » Mais em theguardian.com


  • Heineken ordered to pay €111 million in damages, group announces appeal

    A Dutch court has ordered Heineken to pay €111 million in a dispute between its Greek subsidiary Athenian Brewery and rival Macedonian Thrace Brewery (€43m in damages plus €68m in interest). Heineken plans to appeal, saying the underlying assumptions on sales, pricing and profitability are unrealistic. The case concerns the subsidiary’s conduct between 1998 and 2014; in 2015 Athenian Brewery was already fined by the Greek competition authority. » Mais em t-online.de

Em 2026, Heineken já distribuiu € 1,92 em dividendos. A última distribuição ocorreu em agosto.

Dados financeiros da empresa

No último trimestre, Heineken registou receitas de € 14,84 bi e um ganho líquido de € 1,13 bi
(EUR) junho de 2026
YoY
Receitas 14,84 bi -
Ganho bruto 1,61 bi -
Ganho líquido 1,13 bi -
EBITDA 2,81 bi -

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 46,8 bi
Número de ações
552,38 mi
Máximo/mínimo de 52 semanas
€ 84,80 - € 63,90
Rentabilidade de dividendos
2,26%
Dividendos TTM
€ 1,92
Beta
0,52
PER (PE Ratio)
20,71
PEG (PEG Ratio)
0,35
P/VC (PB Ratio)
2,43
P/V (PS Ratio)
1,28

Perfil da empresa

A Heineken N.V. dedica-se à produção e venda de cerveja e sidra. Também fornece refrigerantes e água. Oferece as suas cervejas sob as marcas Heineken, Amstel, Desperados, Sol, Tiger, Birra Moretti, Affligem, Lagunitas e Mort Subite, bem como sob várias outras marcas regionais e locais; e sidra sob as marcas Strongbow Apple Ciders, Orchard Thieves, Follow The Fox, Cidrerie Stassen, Bulmers, Old Mout e Blind Pig. A empresa disponibiliza os seus produtos a retalhistas, bares, pubs, hotéis e restaurantes na Europa, nas Américas, em África, no Médio Oriente, na Europa de Leste e nos mercados da Ásia-Pacífico. A empresa foi fundada em 1864 e tem sede em Amesterdão, nos Países Baixos. A Heineken N.V. é uma subsidiária da Heineken Holding N.V.

Nome
Heineken
CEO
Rafa de Oliveira
Sede Amsterdam, nh
Países Baixos
Site
Setor
Bens de consumo básico
Indústria
Bebidas
Entrada em bolsa
29/03/1995
Colaboradores 85.000

Símbolos de ticker

Bolsa Símbolo
XETRA
HNK1.DE
Pnk
HINKF
Euronext
HEIA.AS
SIX
HEI.SW
Amsterdam
HEIA.AS
Frankfurt
HNK1.F
Düsseldorf
HNK1.DU
Hamburg
HNK1.HM
London
0O26.L
München
HNK1.MU
Wien
HEIA.VI
🍪

Parqet  utiliza cookies. Saber mais